Compare Illumina, Inc. (ILMN) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs NextEra Energy, Inc. — how do they compare? Illumina, Inc. trades at $189.71 (market cap $27.94B), while NextEra Energy, Inc. trades at $87.84 (market cap $183.53B). The key difference: NextEra Energy, Inc. is far larger — about 6.6× Illumina, Inc.'s market cap, and NextEra Energy, Inc. pays a 2.83% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | NEE | |
|---|---|---|
Market Cap | $27.94B | $183.53B |
Sector | Health | Utilities |
52-Week High | $194.33 | $97.88 |
52-Week Low | $91.00 | $69.77 |
Enterprise Value | $29.33B | $285.94B |
Dividend Yield | — | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
NextEra Energy (NEE) trades at $87.82, down 1.1% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported mixed Q1 2026 earnings, beating estimates with $1.09 EPS versus $1.03 expected, but missed Q4 2025. Revenue for 2025 reached $27.41B with a net income margin of 29.37%. Recent news highlights a planned $59B annual capex through 2032 and a merger filing with Dominion Energy to expand market reach.
Outlook remains positive with analyst consensus price target of $101.88 (16% upside), supported by 66.7% buy ratings. Key risks include high capital expenditures straining cash flow and regulatory hurdles for the Dominion merger. The stock offers growth potential from clean energy investments but faces execution and debt concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
